Psoriasis is one of the most common immune-mediated chronic inflammatory skin disorders, characterized by hyperproliferation of keratinocytes, dilation and growth of dermal capillary vasculature, and cellular infiltration of T cells, dendritic cells ( 
Introduction
Psoriasis is an autoimmune-like chronic inflammatory skin disease affecting up to 3% of the population worldwide (Lowes et al. 2007) . Histologically, psoriasis is characterized by hyperproliferation of keratinocytes, dilation and growth of dermal capillary vasculature, and cellular infiltration of T cells, dendritic cells (DCs) and neutrophils (Christensen et al. 2006; Hegyi et al. 2012; Smits et al. 2006; Sumida et al. 2014) . Although the pathogenesis of psoriasis is not fully elucidated, it is widely accepted that cellular infiltration of T cells, DCs and neutrophils is important in the pathogenesis of psoriasis by provoking inflammation (Boehncke et al. 2015) . Several studies also supported that abundant production of inflammatory cytokines, such as interleukin (IL)-17, interferon (IFN)-γ, IL-6 and tumor necrosis factor-α (TNF-α) plays a key role in the development of this disease (Clark et al. 2006; Lin et al. 2012; Lowes et al. 2008) Total glucosides of paeony (TGP) is an effective constituent purified and extracted from the dried root of Paeonia. The Paeonia lactiflora, which is called 'Shao Yao' in Chinese, has been widely used in China as a therapeutic drug for pain, cramp, congestion and giddiness for more than 1000 years. Recently, TGP has been approved as a novel treatment of rheumatoid arthritis by State Food and Drug Administration (SFDA) of China. Paeoniflorin (PF) is the principal component of TGP, which has been reported with many pharmacological effects such as anti-oxidative, anti-inflammatory and hepatoprotective activities (Sun et al. 2009; Zhang et al. 2008 ).
PF has been used for the treatment of systemic lupus erythematosus (SLE), D r a f t rheumatoid arthritis (RA), Sjögren's syndrome (SS) and other inflammatory and autoimmune diseases (Lin et al. 2012; Wang et al. 2014; Zhao et al. 2012) In order to further extend the understanding of the pharmacological functions of PF and to provide experimental evidence for its potential clinical use in the treatment of psoriasis, the therapeutic effects and the mechanisms of PF in imiquimod (IMQ)-induced psoriasis like mouse model were investigated. The effects of PF on the expression of inflammatory cytokines, such as IL-17, INF-γ, IL-6 and TNF-α in lesional skin in IMQ-induced mice and peripheral blood mononuclear cells (PBMCs) from patients with psoriasis vulgaris were also investigated.
Materials and Methods

Ethics statement
Animal experiments were approved by the Institutional Animal Care and Use Committee of Chengdu Second People's Hospital (Sichuan, China). Human psoriasis studies were approved by the Ethics Committee of Chengdu Second People's Hospital (Sichuan, China). All patients were oriental, and gave written informed consent.
Mice
Six-week-old BALB/c male mice weighting 20-25g were selected for this experiment.
The mice were maintained in specific pathogen-free (SPF) conditions.
Animal model
BALB/c mice were randomly divided into four groups (n =10 per group): Vaseline group, IMQ group, IMQ + PF 50mg/kg group and IMQ + PF 100mg/kg group. A D r a f t daily topical dose of 5% IMQ cream (IMQ group) or control Vaseline (Vaseline group) was applied to the shaved back skin of the mice for 7 consecutive days. PF (molecular weight 480.05, purity 97%) was supplied from Liwah Plant Extraction Technology Co.,Ltd. (Ningbo, China). In this study, PF was dissolved in phosphate-buffered saline (PBS) and injected i.p. at different concentrations. ( IMQ + PF 50mg/kg group and IMQ + PF 100mg/kg group) 0.5 h after IMQ treatment in each day. After 7 days of IMQ administration, we observed the psoriasis symptoms on the backs of the mice and evaluated disease severity with a clinical score. The evaluations were performed by three blinded observers. The scoring system is based on the clinical Psoriasis Area and Severity Index, except for the affected skin area (Shibata et al. 2013) . Erythema, Thickening and scaling were scored independently on scale from 0 to 4: 0 = none; 1 = slight; 2 = moderate; 3 = marked; and 4 = very marked. The cumulative score served as a measure of the severity of inflammation (scale 0-12).
Immunohistochemistry
After 7 days treatment, mice were euthanized. Tissue samples in different groups were obtained. The one part of them was frozen for real-time quantitative PCR, and the other part was used for HE stain and immunohistochemistry. The skin samples of mice were fixed with formalin and embedded in paraffin. Sections (~4 µm) were stained by hematoxylin and eosin and immunohistochemistry using antibody against CD3, CD11c and myeloperoxidase (MPO). Images were acquired using an Olympus BX60 microscope. Quantitative assessments of pathological changes, based on a D r a f t Baker score system, were performed in ten randomly fields (x100) of each HE-stained section to assess the severity of psoriasis (Baker et al. 1992 ). The epidermal proliferation was indicated by the epidermal thickness of back skins.
Cell culture
Twenty patients with psoriasis vulgaris (PV) from Chengdu Second People's Hospital (Sichuan, China) were enrolled in this study. All patients with PV were diagnosed by typical histological finds that including psoriatic acanthosis and Munro's microabscesses. PBMCs from these patients were isolated from heparinized venous blood by Ficoll-Hypaque density gradient centrifugation and cultured in RPMI1640 medium containing 10% FCS, 100 mg/ml penicillin and streptomycin.
Cell viability assay
The effects of PF on cell viability were determined by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay. Cells were seeded in 96-well plates (1×10 4 cells/ well) and treated with PF (10 µM, 100 µM, 1 mM, 5 mM) for 12 h. Cells were washed with PBS twice. Then MTT solution (0.5 mg/ml) was added to each well and cells were incubated at 37°C for 4 h. After centrifuged, 150 µl of dimethylsulfoxide was added to per well for formazan solubilization. The optical densities (O.D.) at 570 nm were determined using a micro-plate reader.
Real-time quantitative PCR
The mRNA levels of IL-17, INF-γ, IL-6 and TNF-α were measured by real-time quantitative PCR. Cells from each patient were divided into two groups and seeded in 6-well plates (2×10 5 cells/ well). Cells were treated with PF (1 mM) or PBS for 12 h. All experiments were carried out in triplicate. Data was expressed as mean ± SD and compared by One-way analysis of variance using the Graphpad Prism 5 software. A P-value <0.05 was considered statistically significant.
Results
PF effectively attenuates psoriatic lesions in IMQ-induced psoriasis like mouse model
To test whether PF is beneficial in IMQ-induced psoriasis like mouse model, mice
were treated with PF 50 mg/kg and 100 mg/kg. One week later, PF was well tolerated, and the mice did not lose weight and showed no signs of sickness. As shown in Fig.1A , we observed the psoriatic lesions characterized by erythema, thickening and scaling in IMQ group. In contrast, PF significantly alleviated the clinical changes in the IMQ-treated mice. Moreover, we assessed disease severity by a clinical score system. We found that PF significantly reduced the semiquantitative clinical score at 7 days after IMQ challenge (Fig.1B) .
PF effectively alleviates the histopathologic changes in IMQ-induced psoriasis like mouse lesions
As presented in Fig.2A , skin histology revealed epidermal thickening, focal parakeratosis, epidermal rete elongation and brisk cellular infiltration of mononuclear cells in the dermis in the IMQ group. PF effectively ameliorated the histological appearance and the infiltrated lymphocytes of the psoriatic lesions compared with the IMQ-control. Furthermore, a Baker score system was used to confirm the pathological score of HE-stained preparations. We indicated that the Baker score was D r a f t significantly increased in IMQ-induced mice relative to Vaseline control group.
However, PF markedly reduced the Baker score for histopathologic changes at 7 day after IMQ induction (Fig.2B ). In addition, we also found that PF effectively reduced the average epidermal thickness compared with the IMQ group (Fig.2C) . These data shows that PF can effectively alleviate the histopathologic changes in IMQ-induced psoriasis like mouse lesions. 
PF reduces the infiltration of T cells, CD11c
Effects of PF on the percentage of cell viability of PBMCs from psoriasis patients in vitro
Cells were treated with PF at concentrations ranging from 10 µM to 5 mM for 12 h.
MTT assay was performed to determine the cytotoxicity. As presented in Fig.S1 , no significant detriment to cell viability was observed when cells were treated with PF < 1 mM for 12 h. However, after exposure to 5 mM PF for 12 h, cell viability decreased to (83.07±15.73) % of the control group. Thus, 1 mM PF was used as the maximum dose throughout subsequent experiments to exclude toxicity.
PF inhibits inflammatory cytokines such as IL-17, INF-γ, IL-6 and TNF-α expression at mRNA levels in PBMCs from psoriasis patients in vitro
To further clarify the anti-inflammatory effects of PF, the mRNA expression of IL-17, differentiation by attenuated phosphorylation of STAT1 and STAT3 (Lin et al. 2012) .
INF-γ, IL-6 and TNF-α in PF treated
Similarly, in this study, we also indicated that PF effectively suppressed the number of T cells, inhibited the expression of IL-17, INF-γ, IL-6 and TNF-α in lesional skin in IMQ-induced mice. In addition, we also found that the expression of IL-4 and IL-10 had not been affected in preliminary study (data not shown). Hence, we suggest that the mechanism of PF in IMQ-induced psoriasis-like mice might be associated with the selectivity damage of abnormal Th1 and Th17 cells, and the reduction of inflammatory cytokines, such as IL-17, INF-γ, IL-6 and TNF-α. To further confirm these effects of PF in human diseases, an in vitro experiment was performed. We found that PF can block the mRNA expression of IL-17, INF-γ, IL-6 and TNF-α in
PBMCs from psoriasis patients. This observation is unlikely to be due to the direct cell toxicity of PF on human PBMCs, because in a supplementary study about 95 % D r a f t of Cell viability was measured when incubated with PF (1 mM) for 12 h by MTT assay. We suggested that PF (1 mM) dose not affect cell viability of PBMCs from healthy control (Fig.S1) . Moreover, the mRNA expression of IL-4 and IL-10 in
PBMCs from psoriasis patients could not be inhibited by PF (data not shown).
In summary, our results provide new evidences for the anti-inflammatory effects of PF in IMQ-induced psoriasis like mice and cultured PBMCs from psoriasis patients.
As showed above, we indicated that PF mainly effectively attenuated the clinical and Pharmacol. 89: 445-453. [Pubmed:21777057] Chen, T., Guo, Z.P., Wang, L., Qin, S., Cao, N., et al. 2013 The levels of IL-17, INF-γ, IL-6 and TNF-α mRNA from back skins in mice (n = 10 per group). GAPDH was used as internal reference gene. Quantitative assessments of pathological score (means ± SD, n=10 per group), based on a Baker score system, were performed in ten randomly fields (x100) of HE-stained sections to evaluate the severity of psoriasis. (C) Average epidermal thickness of all groups (means ± SD, n=10 per group). One-way analysis was used for statistical analysis. P<0.05 was considered to indicate a statistically significant result. ##P<0.01, compared with Vaseline control group; ***P<0.001, compared with IMQ group. 49x31mm (300 x 300 DPI) D r a f t Figure 3 . Immunohistochemistry using antibody against CD3, CD11c and myeloperoxidase (MPO). Mice were treated as described above (ten mice per group). Skin sections were stained with antibodies against CD3, CD11c and MPO. These results were representative of multiple experiments and microscopic fields. Scale bars, 200 µm. 90x99mm (300 x 300 DPI) D r a f t Figure 4 . The levels of IL-17, INF-γ, IL-6 and TNF-α mRNA from back skins in mice (n = 10 per group). GAPDH was used as internal reference gene. One-way analysis was performed and found that the levels of IL-17, INF-γ, IL-6 and TNF-α mRNA from back skins in mice with PF were significantly lower than IMQ group. *P<0.05, **P<0.01, compared with IMQ group; #P<0.05, ##P<0.01, ###P<0.001，compared with Vaseline control group. 57x41mm (600 x 600 DPI) D r a f t Figure 5 . The mRNA expression of IL-17, INF-γ, IL-6 and TNF-α in PF treated PBMCs of psoriasis patients (n = 10 per group). The GAPDH gene was used as the endogenous control. Statistical analysis was conducted using t-test. P<0.05 was considered to indicate a statistically significant result. *P<0.05, **P<0.01. 57x41mm (600 x 600 DPI)
